These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 23573608

  • 1. Current use of atypical antipsychotics.
    Müller-Spahn F.
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():377s-384s. PubMed ID: 23573608
    [Abstract] [Full Text] [Related]

  • 2. Amisulpride: a review of its use in the management of schizophrenia.
    Curran MP, Perry CM.
    Drugs; 2001 Aug; 61(14):2123-50. PubMed ID: 11735643
    [Abstract] [Full Text] [Related]

  • 3. Spotlight on amisulpride in schizophrenia.
    Curran MP, Perry CM.
    CNS Drugs; 2002 Aug; 16(3):207-11. PubMed ID: 11888341
    [Abstract] [Full Text] [Related]

  • 4. Atypical antipsychotics: mechanism of action.
    Seeman P.
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [Abstract] [Full Text] [Related]

  • 5. Amisulpride: a review of its use in the management of schizophrenia.
    McKeage K, Plosker GL.
    CNS Drugs; 2004 Feb; 18(13):933-56. PubMed ID: 15521794
    [Abstract] [Full Text] [Related]

  • 6. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T, Bonsack C.
    Encephale; 2006 Feb; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S, Remington G.
    Annu Rev Med; 2001 Feb; 52():503-17. PubMed ID: 11160792
    [Abstract] [Full Text] [Related]

  • 11. Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents.
    Glick ID, Lemmens P, Vester-Blokland E.
    Int Clin Psychopharmacol; 2001 Sep; 16(5):265-74. PubMed ID: 11552769
    [Abstract] [Full Text] [Related]

  • 12. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 13. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H, Claustre Y, Fage D, Rouquier L, Chergui K, Curet O, Oblin A, Gonon F, Carter C, Benavides J, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T, Perry CM.
    Drugs; 2004 Jan; 64(15):1715-36. PubMed ID: 15257633
    [Abstract] [Full Text] [Related]

  • 20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.